Supernus strikes $400M+ Adamas buyout as its top drug heads toward the patent cliff esagonowsky Mon, 10/11/2021 – 15:06 More: Supernus strikes 0M+ Adamas buyout as its top drug heads toward the patent cliff Source: fierce
read morePacira boosts nonopioid pain portfolio via $450M Flexion buy, with more CVR payments to come aliu Mon, 10/11/2021 – 11:27 More: Pacira boosts nonopioid pain portfolio via 0M Flexion buy, with more CVR payments to come Source: fierce
read moreIpsen poaches Novartis vet Mari Scheiffele to serve as president of its international specialty care team esagonowsky Mon, 10/11/2021 – 11:06 More: Ipsen poaches Novartis vet Mari Scheiffele to serve as president of its international specialty care team Source: fierce
read moreBoehringer capacity exceeds original forecast at new $809M Austrian plant jkeenan Mon, 10/11/2021 – 09:50 More: Boehringer capacity exceeds original forecast at new 9M Austrian plant Source: fierce
read moreTimber posts data on topical Accutane, readies for pivotal trial ntaylor Mon, 10/11/2021 – 09:42 More: Timber posts data on topical Accutane, readies for pivotal trial Source: fierce
read morePharmacies saw increased customer demand during the pandemic, says UHY Hacker Young More: UK pharmacy M&A transactions up by 26% Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals